NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 1 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $310,000 | -92.5% | 168,700 | -70.2% | 0.00% | -85.7% |
| Q2 2016 | $4,116,000 | +39.1% | 566,100 | -1.2% | 0.01% | +16.7% |
| Q1 2016 | $2,958,000 | -38.9% | 573,200 | -0.6% | 0.01% | -40.0% |
| Q4 2015 | $4,839,000 | +27.5% | 576,800 | +7.5% | 0.01% | +42.9% |
| Q3 2015 | $3,795,000 | -37.8% | 536,800 | -1.9% | 0.01% | -36.4% |
| Q2 2015 | $6,098,000 | +33.5% | 547,400 | -0.9% | 0.01% | +37.5% |
| Q1 2015 | $4,569,000 | +185.9% | 552,500 | +105.0% | 0.01% | +166.7% |
| Q4 2014 | $1,598,000 | +52.5% | 269,500 | +7.2% | 0.00% | +50.0% |
| Q3 2014 | $1,048,000 | -1.5% | 251,400 | +9.2% | 0.00% | 0.0% |
| Q2 2014 | $1,064,000 | +77.9% | 230,200 | +74.4% | 0.00% | +100.0% |
| Q1 2014 | $598,000 | -27.0% | 132,000 | -17.5% | 0.00% | -50.0% |
| Q4 2013 | $819,000 | +1.7% | 160,000 | -37.2% | 0.00% | 0.0% |
| Q3 2013 | $805,000 | – | 254,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |